Department of Radiology, Division of Interventional Radiology, University of Minnesota, Minneapolis, MN.
Department of Radiology, Division of Interventional Radiology, University of Minnesota, Minneapolis, MN.
Tech Vasc Interv Radiol. 2020 Sep;23(3):100695. doi: 10.1016/j.tvir.2020.100695. Epub 2020 Oct 5.
Medically refractory benign prostatic hyperplasia induced lower urinary tract symptoms is an extremely prevalent issue in older men. The current gold standard therapy transurethral resection of the prostate does produce urologic improvements but is also associated with higher than desired morbidity. This has led to the need to develop new minimally invasive means to treat this disease; prostate artery embolization (PAE) has emerged as one minimally invasive treatment option for these patients. The body of evidence which supports the use of PAE has grown quickly and substantially over the last decade. The goal of this review is to introduce and summarize the published urologic outcomes for PAE when utilized to treat benign prostatic hyperplasia induced lower urinary tract symptoms as well as document the established complication profile. Finally, the paper reviews current societal recommendations as they relate to PAE.
医学上无法治疗的良性前列腺增生引起的下尿路症状是老年男性中极其普遍的问题。目前的金标准治疗方法经尿道前列腺切除术确实可以改善泌尿科问题，但也与预期过高的发病率相关。这导致需要开发新的微创手段来治疗这种疾病；前列腺动脉栓塞术 (PAE) 已成为这些患者的一种微创治疗选择。过去十年中，支持使用 PAE 的证据迅速大量增加。本综述的目的是介绍和总结 PAE 用于治疗良性前列腺增生引起的下尿路症状的已发表泌尿科结果，并记录已确定的并发症概况。最后，本文回顾了与 PAE 相关的当前社会建议。
